NEPTUNE, N.J.--(EON: Enhanced Online News)--Excelsior Medical Inc. today announced it has received a Federal Supply Schedule (FSS) contract with the U.S. Veterans Administration (VA). The contract, which begins Nov. 1, 2013, covers Excelsior’s line of prefilled flush syringes and disinfection caps for IV needleless connectors, including its SwabCap and SwabFlush products.
“The FSS contract will allow us the opportunity to continue to expand our relationships with federal healthcare providers and to add further value within the VA and DOD systems.”
Excelsior already has a Distribution and Price Agreement (DAPA) with the Defense Logistics Agency (DLA) to sell products into the military healthcare system. The FSS contract awarded by the Department of Veterans Affairs (DVA) healthcare system means both VA and Department of Defense (DOD) hospitals and clinics are now able to buy Excelsior’s products.
“Excelsior has already worked with a number of VA facilities to help to develop more effective disinfection protocols for IV needleless connectors, by including our SwabCap and SwabFlush technologies,” said Steven Thornton, CEO of Excelsior Medical. “The FSS contract will allow us the opportunity to continue to expand our relationships with federal healthcare providers and to add further value within the VA and DOD systems.”
SwabCap is a disinfection cap designed to disinfect the top and threads of IV luer-lock needleless connectors with 70% isopropyl alcohol when attached to the connector hub. Left in place on the connector between line accesses, SwabCap then protects the connector from touch and airborne contamination.
SwabFlush is the only device that combines a saline flush syringe and disinfection cap. This combination is intended to improve compliance with disinfection protocols because the SwabCap is built into the syringe plunger, making it immediately and conveniently available to nurses after they flush an I.V. line.
SwabCap and SwabFlush have been the subject of numerous award-winning scientific presentations by independent clinician users. These include research presented at recent annual meetings of the Association for Vascular Access (AVA), Association for Professionals in Infection Control and Epidemiology (APIC), and the Children's Hospital Association (formerly NACHRI).1
About Excelsior Medical Incorporated
Excelsior Medical Corporation is a privately held medical device company with a primary focus on innovative catheter maintenance products that may improve disinfection and reduce medication errors and healthcare costs. The company manufactures and sells SwabCap and SwabFlush for the disinfection and protection of IV needleless connectors. Formed in 1989, Excelsior also manufactures and sells prefilled saline flush syringes, prefilled heparin flush and lock syringes, and syringe pump systems. For more information, call 800-487-4276 or access www.excelsiormedical.com
1. Awards and recognition of studies were noted during annual meetings of the Association for Vascular Access (2013), Association for Professionals in Infection Control and Epidemiology (2012), and the National Association of Children's Hospitals and Related Institutions (2011).